Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Ono Pharmaceutical Co. Ltd. ADR (ON40)
Market Closed
3 Jun, 20:00
XMUN
All
(2)
DE
(1)
US
(1)
OTC PINK
Primary
XMUN
4.
1200
-0.14
-3.29%
6.2B
Market Cap
8.61
P/E Ratio
0.18%
Div Yield
0
Volume
0
Eps
4.26
Previous Close
Watching
Watch
Add Transaction
Day Range
4.12
4.12
Year Range
3.1
4.62
Want to track
ON40
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
Historical Data
Ono Pharmaceutical Co. Ltd. ADR (ON40) Statistics
Valuation metrics
Market Cap
6.2B
Enterprise value
-585.46M
Trailing P/E (ttm)
16.3
Forward P/E
-
PEG ratio
-0.28
Price/Sales (ttm)
0.01
Price/Book (mrq)
1.39
Enterprise Value/Revenue
-0.21
Enterprise Value/EBITDA
-0.83
Overview
Shares outstanding
1.41B
Float
453.49M
Shares short
-
% Held by insiders
-
% Held by institutions
0%
Average volume (10 days)
3
Average volume (90 days)
1
Price summary
52-Week low
3.1
52-Week high
4.62
Beta
0.11
50-Day moving average
4.4
200-Day moving average
3.9
Dividends and splits
Forward annual dividend rate
0.15
Forward annual dividend yield
0.0336%
Trailing annual dividend rate
0.15
Trailing annual dividend yield
0.0346%
5-Year annual dividend yield
-
Payout ratio
0.26
Dividend Date
7 Oct 2025
Ex-Dividend Date
30 Sep 2025
Last split factor
3:1
Last split Date
4 Apr 2016
Financials
Fiscal year
Fiscal year ends
31 Mar 2026
Most recent quarter (mrq)
30 Jun 2025
Profitability
Profit margin
0.14%
Operating margin
0.03%
Operational effectiveness
Return on assets
0.05%
Return on equity
0.09%
Income Statement
Revenue (ttm)
2.79B
Revenue per share (ttm)
365.55
Quarterly revenue growth (yoy)
0.06%
Gross profit (ttm)
2.02B
EBITDA
91.54B
Net income to common (ttm)
377.55M
Diluted EPS (ttm)
0.27
Quarterly earnings growth (yoy)
0.93%
Balance Sheet
Total cash (mrq)
1.28B
Total cash per share (mrq)
504.58
Total debt (mrq)
654.45M
Total Debt/Equity (mrq)
14.12
Current ratio (mrq)
2.86%
Book value per share (mrq)
3.18
Cash Flow
Cash flow statement
740.42M
Levered free cash flow (LFCF)
350.85M